CPHI vs PSA · rev $4.1M vs rev $4.82B
China Pharma Holdings Inc (CPHI) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
PSA (PSA) common stock.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
CPHI currently screens at market cap $29.0M. PSA currently screens at market cap $0.
Not investment advice. Open the CPHI and PSA stock pages for the full models.
Not investment advice.